Corrigall et al. reported that recombinant human Grp78 (rhGrp78) could prevent the induction of experimental arthritis when it was given i.v. before the induction of CIA (14) or during active disease to induce permanent remission of inflammation in CIA (15). This evidence concerns the gene HSPA5 and arthritic joint disease.